---
title: "QUALASEPT PHARMAXO HOLDINGS LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/54d5b20c-b1e1-50cd-9a27-86cff337bc88
json: https://whiteintel.dev/api/public/dossier/54d5b20c-b1e1-50cd-9a27-86cff337bc88
identifier: oo:GB-COH-06981369
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# QUALASEPT PHARMAXO HOLDINGS LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-06981369`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/54d5b20c-b1e1-50cd-9a27-86cff337bc88  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/54d5b20c-b1e1-50cd-9a27-86cff337bc88  

## Ownership & control

### Owners / controllers

- **Mr Richard John Wastnage** (beneficial owner) — 50% — https://whiteintel.dev/entity/22956500-cb92-5b42-aae5-a6e4bcfbfab5
- **Mr Christopher Dean Watt** (beneficial owner) — 50% — https://whiteintel.dev/entity/1a057098-1704-5ff1-8759-856a7dc2a1f3
- **QUALASEPT HOLDINGS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/cfa981c1-7a3d-5689-8188-a3c0f3db7d57
- **Mr Christopher Dean Watt** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/890f005e-04f4-4a6f-a0f3-a1cff92afe1f
- **Mr Richard John Wastnage** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/51b205d6-71f1-4f93-83df-62694b1b056a
- **QUALASEPT HOLDINGS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/cfa981c1-7a3d-5689-8188-a3c0f3db7d57

### Holdings / subsidiaries

- **CORSHAM SCIENCE LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/37d11124-dca0-5b66-9072-fa3cabbeb641
- **PHARMAXO PHARMACY SERVICES LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/244edb67-e615-5f23-b9f3-f9171723dec8
- **MICROGENETICS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/b82b47d3-62ff-5c8a-aed4-372b1ee9b4ea
- **QUALASEPT LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/7a87d1b4-eb9c-5680-96e8-28f605cc9a50
- **CORSHAM SCIENCE LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/37d11124-dca0-5b66-9072-fa3cabbeb641
- **PHARMAXO PHARMACY SERVICES LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/244edb67-e615-5f23-b9f3-f9171723dec8
- **QUALASEPT LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/7a87d1b4-eb9c-5680-96e8-28f605cc9a50
- **MICROGENETICS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/b82b47d3-62ff-5c8a-aed4-372b1ee9b4ea

### UBO chain (walk to the ultimate owner)

A **24-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `06981369`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2009-08-05
- **Registered office:** 3 Corsham Science Park, Park Lane, Corsham, Wiltshire, SN13 9FU, United Kingdom
- **SIC:** 70100

### Officers

- MIDDLETON, Mark Geoffrey — director · Australian · appointed 2025-02-01
- MUIR, Ian Stuart — director · British · appointed 2022-04-05
- ROBINSON, Andrew, Mr. — director · British · appointed 2023-08-01
- HAMILTON JENNINGS, Katherine — secretary · appointed 2021-07-12 · resigned 2023-02-13
- WHITE, Victoria — secretary · appointed 2017-07-26 · resigned 2019-01-14
- ALSOP, Andrew John — director · British · appointed 2016-10-25 · resigned 2023-12-31
- DAVIES, Andrew Charles — director · British · appointed 2019-06-18 · resigned 2023-03-31
- DAVIS, Alison Maria — director · British · appointed 2016-09-27 · resigned 2024-08-01
- FOUNTAIN, Christopher James — director · British · appointed 2016-11-21 · resigned 2022-03-31
- RODERICK, Mark Edward — director · British · appointed 2019-06-18 · resigned 2022-04-14
- SLADE, David, Mr. — director · Australian · appointed 2024-08-01 · resigned 2025-02-01
- WASTNAGE, Richard John — director · British · appointed 2009-08-05 · resigned 2024-08-01
- WATT, Christopher Dean — director · British · appointed 2009-08-05 · resigned 2024-08-01
- WATT, Maria Ann — director · British · appointed 2009-08-05 · resigned 2021-06-18

### Beneficial owners (Persons with Significant Control)

- [Qualasept Holdings Limited](https://whiteintel.dev/entity/cfa981c1-7a3d-5689-8188-a3c0f3db7d57) — 75–100% shares · corporate PSC · England & Wales — since 2016-06-22
- Mr Richard John Wastnage — 25–50% shares · individual PSC — ceased 2016-06-21
- Mr Christopher Dean Watt — 25–50% shares · individual PSC — ceased 2016-06-21

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/06981369
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/06981369

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **QUALASEPT PHARMAXO HOLDINGS LIMITED** — https://whiteintel.dev/entity/54d5b20c-b1e1-50cd-9a27-86cff337bc88 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **QUALASEPT PHARMAXO HOLDINGS LIMITED**. Human view: https://whiteintel.dev/entity/54d5b20c-b1e1-50cd-9a27-86cff337bc88 · Structured JSON: https://whiteintel.dev/api/public/dossier/54d5b20c-b1e1-50cd-9a27-86cff337bc88._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._